Note: This document contains side effect information about crofelemer. Some of the dosage forms listed on this page may not apply to the brand name Fulyzaq.
More frequent side effects include: upper respiratory tract infection. See below for a comprehensive list of adverse effects.
Applies to crofelemer: oral tablet delayed release
Along with its needed effects, crofelemer (the active ingredient contained in Fulyzaq) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking crofelemer:
Some side effects of crofelemer may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Applies to crofelemer: oral delayed release tablet
Common (1% to 10%): Acne, dermatitis
Common (1% to 10%): Flatulence, nausea, hemorrhoids, abdominal distension, abdominal pain, constipation, dry mouth, dyspepsia, gastroenteritis
The most common adverse reactions (greater than or equal to 3%) include upper respiratory tract infection, bronchitis, cough, flatulence and increased bilirubin.
Common (1% to 10%): Urinary tract infection, pollakiuria
Common (1% to 10%): Decreased white blood cell count
Common (1% to 10%): Increased bilirubin, increased alanine aminotransferase, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, nephrolithiasis
Common (1% to 10%): Back pain, arthralgia, musculoskeletal pain, pain in extremity
Common (1% to 10%): Dizziness
Common (1% to 10%): Giardiasis, herpes zoster, procedural pain, seasonal allergy
Common (1% to 10%): Anxiety, depression
Common (1% to 10%): Upper respiratory tract infection, bronchitis, cough, nasopharyngitis, sinusitis
Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.
Source: Drugs.com Fulyzaq